Adenovirus types 4 and 7 live oral vaccine Approval History
- FDA approved: Yes (First approved March 16th, 2011)
- Generic name: adenovirus types 4 and 7 live oral vaccine
- Company: Barr Laboratories Inc
- Treatment for: Infection Prophylaxis
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral is a vaccine indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type in military populations 17 through 50 years of age.
Development History and FDA Approval Process for adenovirus types 4 and 7 live oral vaccine
|Dec 11, 2008||Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.